SOPHIA GENETICS SA (NASDAQ: SOPH)

SOPHIA GENETICS SA

NASDAQ: SOPH (SOPHiA GENETICS SA)

Last update: 10 Apr, 7:48AM

4.73

-0.13 (-2.67%)

Add to watchlist

Previous Close	4.86
Open	4.80
Volume	42,887
Avg. Volume (3M)	197,093
Market Cap	338,992,960

Price / Sales	4.41
Price / Book	7.67

52 Weeks Range	2.58 (-45%) — 5.70 (20%)
Earnings Date	5 May 2026

Market Trend

		Short Term	Medium Term
Industry	Health Information Services (US)	Bearish	Mixed
	Health Information Services (Global)	Bearish	Mixed
Stock	SOPHiA GENETICS SA	Mixed	Bearish

AIStockmoo Score

1.1

Analyst Consensus	-0.5
Insider Activity	2.0
Price Volatility	-2.0
Technical Moving Averages	3.5
Technical Oscillators	2.5
Average	1.10

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
SOPH	339 M	-	-	7.67
OMCL	2 B	-	830.75	1.39
PGNY	1 B	-	27.88	2.61
SDGR	911 M	-	-	2.45
CERT	883 M	-	-	0.900
GDRX	750 M	-	24.33	1.15

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Sector	Healthcare
Industry	Health Information Services
Investment Style	Small Core
% Held by Insiders	6.53%
% Held by Institutions	58.92%

Ownership

Name	Date	Shares Held
Alta Wealth Advisors Llc	31 Dec 2025	1,409,160
Bank Pictet & Cie (Europe) Ag	31 Dec 2025	255,200

52 Weeks Range	2.58 (-45%) — 5.70 (20%)
Median	7.00 (47.99%)
Total	1 Buy

Firm	Date	Target Price	Call	Price @ Call
Guggenheim	26 Jan 2026	7.00 (47.99%)	Buy	5.32

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
CAMBLONG JURGI	-	4.93	-5,100	-25,120
CARDOZA GEORGE	-	4.93	-4,933	-24,298
MENU PHILIPPE	-	4.93	-5,100	-25,125
MUKEN ROSS	-	4.93	-5,024	-24,748
PUYLAERT KEVIN	-	4.95	-624	-3,089
VALENTE MANUELA	-	4.93	-4,973	-24,498
VAN WELL DAAN	-	4.93	-5,105	-25,150
VERMA ABHIMANYU	-	4.93	-3,549	-17,516
XU ZHENYU	-	4.93	-5,100	-25,125
Aggregate Net Quantity				-39,508
Aggregate Net Value ($)				-194,667
Aggregate Avg. Buy ($)				-
Aggregate Avg. Sell ($)				4.93

Name	Holder	Date	Type	Quantity	Price	Value ($)
VERMA ABHIMANYU	Officer	07 Apr 2026	Automatic sell (-)	1,030	4.90	5,047
XU ZHENYU	Officer	07 Apr 2026	Automatic sell (-)	2,400	4.90	11,760
VALENTE MANUELA	Officer	07 Apr 2026	Automatic sell (-)	2,376	4.90	11,642
CARDOZA GEORGE	Officer	07 Apr 2026	Automatic sell (-)	2,413	4.90	11,824
CAMBLONG JURGI	Officer	07 Apr 2026	Automatic sell (-)	2,500	4.90	12,250
MUKEN ROSS	Officer	07 Apr 2026	Automatic sell (-)	2,424	4.90	11,878
VAN WELL DAAN	Officer	07 Apr 2026	Automatic sell (-)	2,400	4.90	11,760
MENU PHILIPPE	Officer	07 Apr 2026	Automatic sell (-)	2,400	4.90	11,760
VERMA ABHIMANYU	Officer	06 Apr 2026	Automatic sell (-)	2,519	4.95	12,469
XU ZHENYU	Officer	06 Apr 2026	Automatic sell (-)	2,700	4.95	13,365
VALENTE MANUELA	Officer	06 Apr 2026	Automatic sell (-)	2,597	4.95	12,855
CARDOZA GEORGE	Officer	06 Apr 2026	Automatic sell (-)	2,520	4.95	12,474
CAMBLONG JURGI	Officer	06 Apr 2026	Automatic sell (-)	2,600	4.95	12,870
MUKEN ROSS	Officer	06 Apr 2026	Automatic sell (-)	2,600	4.95	12,870
VAN WELL DAAN	Officer	06 Apr 2026	Automatic sell (-)	2,705	4.95	13,390
MENU PHILIPPE	Officer	06 Apr 2026	Automatic sell (-)	2,700	4.95	13,365
PUYLAERT KEVIN	Officer	06 Apr 2026	Sell (-)	624	4.95	3,089
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	-98.51%
Operating Margin (TTM)	-90.20%
Diluted EPS (TTM)	-1.00
Quarterly Revenue Growth (YOY)	12.70%

Total Debt/Equity (MRQ)	35.19%
Current Ratio (MRQ)	3.11
Operating Cash Flow (TTM)	-38.93 M
Levered Free Cash Flow (TTM)	-24.65 M

Return on Assets (TTM)	-24.41%
Return on Equity (TTM)	-60.75%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)